Zebrafish: An Important Tool for Liver Disease Research

Biliary atresia is a severe cholangiopathy of early infancy that destroys extrahepatic bile ducts and disrupts bile flow. With a poorly defined disease pathogenesis, treatment consists of the surgical removal of duct remnants followed by hepatoportoenterostomy. Although this approach can improve the short-term outcome, the liver disease progresses to end-stage cirrhosis in most children. Further improvement in outcome will require a greater understanding of the mechanisms of biliary injury and fibrosis. Here, we review progress in the field, which has been fuelled by collaborative studies in larger patient cohorts and the development of cell culture and animal model systems to directly test hypotheses. Advances include the identification of phenotypic subgroups and stages of disease based on clinical, pathological and molecular features. Stronger evidence exists for viruses, toxins and gene sequence variations in the aetiology of biliary atresia, triggering a proinflammatory response that injures the duct epithelium and produces a rapidly progressive cholangiopathy. The immune response also activates the expression of type 2 cytokines that promote epithelial cell proliferation and extracellular matrix production by nonparenchymal cells. These advances provide insight into phenotype variability and might be relevant to the design of personalized trials to block progression of liver disease.

/pdf/pathogenesis-of-biliary-atresia-defining-biology-to-4x2zhbz4ii.pdf

Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes

Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century

Development of the liver: Insights into organ and tissue morphogenesis

https://kclpure.kcl.ac.uk/portal/files/51818077/1_s2.0_S0168827816301866_main.pdf

Biliary atresia and other cholestatic childhood diseases: Advances and future challenges

https://www.gastrojournal.org/article/S0016-5085(13)00079-6/pdf

Melissa Leyva–Vega

Papers

Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene.